Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study
October 23, 2026
October 23, 2026
ROCHESTER, Minnesota, Oct. 23 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study
*
ROCHESTER, Minn. -- An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers. . . .
* * *
Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study
*
ROCHESTER, Minn. -- An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers. . . .